Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2024

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Prepaid clinical trial	$	1,772	$	802
Prepaid research and development		1,083		1,412
Prepaid bonus		66		—
Prepaid insurance		32		292
Deferred offering costs		—		681
Other		465		292
Total prepaid expenses and other current assets	$	3,418	$	3,479

Schedule of Property Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):

	September 30, 2024			December 31, 2023
Leasehold improvements	$	2,117		$	2,117
Laboratory equipment		3,002			2,868
Computer equipment		1,309			1,133
Furniture and fixtures		864			864
Construction in progress		4,235			6,823
		11,527			13,805
Accumulated depreciation		(3,914	)		(2,979	)
Property, plant and equipment, net	$	7,613		$	10,826

Schedule of Accrued Expense and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Accrued compensation	$	3,894	$	3,423
Accrued clinical trial		2,926		1,851
Accrued research and development		1,960		3,467
Lease liabilities, current portion		1,815		1,646
Accrued professional and consulting fees		616		330
Warrant liability		521		454
Accrued severance		—		390
Other		876		723
Total accrued expenses and other current liabilities	$	12,608	$	12,284